Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer - Concepedia

Concepedia

Publication | Closed Access

Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer

38

Citations

20

References

2012

Year

J. Falke, Rianne J.M. Lammers, H.C. Arentsen, M. Ravic, Raffaella Pozzi, Erik B. Cornel, H. Vergunst, Theo M. de Reijke, J. Alfred Witjes

The Journal of Urology

Abstract

Intravesical treatment with TMX-101 is safe. The side effects are common but mild and mostly limited to the genitourinary tract. There is a low systemic uptake.

References

	Year	Citations

Page 1